APO Research
Talk to an analyst

APO RESEARCH · REPORT

Consumer Healthcare Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Consumer Healthcare Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025199 pages

Choose your research edition.

Industry ResearchConsumer Healthcare Drug Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Consumer Healthcare Drug Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Consumer Healthcare Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Consumer Healthcare Drug Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Consumer Healthcare Drug Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Consumer Healthcare Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Consumer Healthcare Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Consumer Healthcare Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Consumer Healthcare Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Consumer Healthcare Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Consumer Healthcare Drug include Takeda, Teva, Shanghai Pharmaceuticals, Sanofi, Johnson & Johnson, Merck & Co., Pfizer, Hualan Bio and North China Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Consumer Healthcare Drug market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Consumer Healthcare Drug and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Consumer Healthcare Drug revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Consumer Healthcare Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Consumer Healthcare Drug Segment by Company

Takeda

Teva

Shanghai Pharmaceuticals

Sanofi

Johnson & Johnson

Merck & Co.

Pfizer

Hualan Bio

North China Pharmaceutical

Hengrui Medicine

GlaxoSmithKline

Bayer

AbbVie

Sinopharm Group

Livzon Group

Fosun Pharma

East China Medicine

CR Pharmaceutical

Consumer Healthcare Drug Segment by Type

Patch

Oral Liquid

Solid Preparations

Other

Consumer Healthcare Drug Segment by Application

Hospital

Retail Pharmacy

Other

Consumer Healthcare Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Consumer Healthcare Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Consumer Healthcare Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Consumer Healthcare Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Consumer Healthcare Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Consumer Healthcare Drug industry.

Chapter 3: Detailed analysis of Consumer Healthcare Drug companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Consumer Healthcare Drugrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Consumer Healthcare Drug Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Patch Table 3. Key Players of Oral Liquid Table 4. Key Players of Solid Preparations Table 3. Key Players of Other Table 4. Global Consumer Healthcare Drug Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Retail Pharmacy Table 7. Key Players of Other Table 8. Global Consumer Healthcare Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Consumer Healthcare Drug Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Consumer Healthcare Drug Market Share by Region (2021-2026) Table 11. Global Consumer Healthcare Drug Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Consumer Healthcare Drug Market Share by Region (2027-2032) Table 13. Consumer Healthcare Drug Industry Trends Table 14. Consumer Healthcare Drug Industry Drivers Table 15. Consumer Healthcare Drug Industry Opportunities and Challenges Table 16. Consumer Healthcare Drug Industry Restraints Table 17. Global Consumer Healthcare Drug Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Consumer Healthcare Drug Revenue Market Share by Company (2021-2026) Table 19. Global Consumer Healthcare Drug Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Consumer Healthcare Drug Key Company Head Office and Area Served Table 21. Global Consumer Healthcare Drug Company, Product Type & Application Table 22. Global Consumer Healthcare Drug Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Consumer Healthcare Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Consumer Healthcare Drug Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Consumer Healthcare Drug Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Consumer Healthcare Drug Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Consumer Healthcare Drug Revenue Market Share by Type (2021-2026) Table 29. Global Consumer Healthcare Drug Revenue Market Share by Type (2027-2032) Table 30. Global Consumer Healthcare Drug Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Consumer Healthcare Drug Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Consumer Healthcare Drug Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Consumer Healthcare Drug Revenue Market Share by Application (2021-2026) Table 34. Global Consumer Healthcare Drug Revenue Market Share by Application (2027-2032) Table 35. Takeda Company Information Table 36. Takeda Business Overview Table 37. Takeda Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Takeda Consumer Healthcare Drug Product Portfolio Table 39. Takeda Recent Development Table 40. Teva Company Information Table 41. Teva Business Overview Table 42. Teva Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Teva Consumer Healthcare Drug Product Portfolio Table 44. Teva Recent Development Table 45. Shanghai Pharmaceuticals Company Information Table 46. Shanghai Pharmaceuticals Business Overview Table 47. Shanghai Pharmaceuticals Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Shanghai Pharmaceuticals Consumer Healthcare Drug Product Portfolio Table 49. Shanghai Pharmaceuticals Recent Development Table 50. Sanofi Company Information Table 51. Sanofi Business Overview Table 52. Sanofi Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Sanofi Consumer Healthcare Drug Product Portfolio Table 54. Sanofi Recent Development Table 55. Johnson & Johnson Company Information Table 56. Johnson & Johnson Business Overview Table 57. Johnson & Johnson Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Johnson & Johnson Consumer Healthcare Drug Product Portfolio Table 59. Johnson & Johnson Recent Development Table 60. Merck & Co. Company Information Table 61. Merck & Co. Business Overview Table 62. Merck & Co. Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Merck & Co. Consumer Healthcare Drug Product Portfolio Table 64. Merck & Co. Recent Development Table 65. Pfizer Company Information Table 66. Pfizer Business Overview Table 67. Pfizer Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Pfizer Consumer Healthcare Drug Product Portfolio Table 69. Pfizer Recent Development Table 70. Hualan Bio Company Information Table 71. Hualan Bio Business Overview Table 72. Hualan Bio Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Hualan Bio Consumer Healthcare Drug Product Portfolio Table 74. Hualan Bio Recent Development Table 75. North China Pharmaceutical Company Information Table 76. North China Pharmaceutical Business Overview Table 77. North China Pharmaceutical Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. North China Pharmaceutical Consumer Healthcare Drug Product Portfolio Table 79. North China Pharmaceutical Recent Development Table 80. Hengrui Medicine Company Information Table 81. Hengrui Medicine Business Overview Table 82. Hengrui Medicine Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Hengrui Medicine Consumer Healthcare Drug Product Portfolio Table 84. Hengrui Medicine Recent Development Table 85. GlaxoSmithKline Company Information Table 86. GlaxoSmithKline Business Overview Table 87. GlaxoSmithKline Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. GlaxoSmithKline Consumer Healthcare Drug Product Portfolio Table 89. GlaxoSmithKline Recent Development Table 90. Bayer Company Information Table 91. Bayer Business Overview Table 92. Bayer Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Bayer Consumer Healthcare Drug Product Portfolio Table 94. Bayer Recent Development Table 95. AbbVie Company Information Table 96. AbbVie Business Overview Table 97. AbbVie Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. AbbVie Consumer Healthcare Drug Product Portfolio Table 99. AbbVie Recent Development Table 100. Sinopharm Group Company Information Table 101. Sinopharm Group Business Overview Table 102. Sinopharm Group Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. Sinopharm Group Consumer Healthcare Drug Product Portfolio Table 104. Sinopharm Group Recent Development Table 105. Livzon Group Company Information Table 106. Livzon Group Business Overview Table 107. Livzon Group Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. Livzon Group Consumer Healthcare Drug Product Portfolio Table 109. Livzon Group Recent Development Table 110. Fosun Pharma Company Information Table 111. Fosun Pharma Business Overview Table 112. Fosun Pharma Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. Fosun Pharma Consumer Healthcare Drug Product Portfolio Table 114. Fosun Pharma Recent Development Table 115. East China Medicine Company Information Table 116. East China Medicine Business Overview Table 117. East China Medicine Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 118. East China Medicine Consumer Healthcare Drug Product Portfolio Table 119. East China Medicine Recent Development Table 120. CR Pharmaceutical Company Information Table 121. CR Pharmaceutical Business Overview Table 122. CR Pharmaceutical Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 123. CR Pharmaceutical Consumer Healthcare Drug Product Portfolio Table 124. CR Pharmaceutical Recent Development Table 125. North America Consumer Healthcare Drug Market Size by Type (2021-2026) & (US$ Million) Table 126. North America Consumer Healthcare Drug Market Size by Type (2027-2032) & (US$ Million) Table 127. North America Consumer Healthcare Drug Market Size by Application (2021-2026) & (US$ Million) Table 128. North America Consumer Healthcare Drug Market Size by Application (2027-2032) & (US$ Million) Table 129. North America Consumer Healthcare Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. North America Consumer Healthcare Drug Market Size by Country (2021-2026) Table 131. North America Consumer Healthcare Drug Market Size by Country (2027-2032) Table 132. Europe Consumer Healthcare Drug Market Size by Type (2021-2026) & (US$ Million) Table 133. Europe Consumer Healthcare Drug Market Size by Type (2027-2032) & (US$ Million) Table 134. Europe Consumer Healthcare Drug Market Size by Application (2021-2026) & (US$ Million) Table 135. Europe Consumer Healthcare Drug Market Size by Application (2027-2032) & (US$ Million) Table 136. Europe Consumer Healthcare Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Europe Consumer Healthcare Drug Market Size by Country (2021-2026) Table 138. Europe Consumer Healthcare Drug Market Size by Country (2027-2032) Table 139. China Consumer Healthcare Drug Market Size by Type (2021-2026) & (US$ Million) Table 140. China Consumer Healthcare Drug Market Size by Type (2027-2032) & (US$ Million) Table 141. China Consumer Healthcare Drug Market Size by Application (2021-2026) & (US$ Million) Table 142. China Consumer Healthcare Drug Market Size by Application (2027-2032) & (US$ Million) Table 143. Asia Consumer Healthcare Drug Market Size by Type (2021-2026) & (US$ Million) Table 144. Asia Consumer Healthcare Drug Market Size by Type (2027-2032) & (US$ Million) Table 145. Asia Consumer Healthcare Drug Market Size by Application (2021-2026) & (US$ Million) Table 146. Asia Consumer Healthcare Drug Market Size by Application (2027-2032) & (US$ Million) Table 147. Asia Consumer Healthcare Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Asia Consumer Healthcare Drug Market Size by Country (2021-2026) Table 149. Asia Consumer Healthcare Drug Market Size by Country (2027-2032) Table 150. South America, Middle East & Africa Consumer Healthcare Drug Market Size by Type (2021-2026) & (US$ Million) Table 151. South America, Middle East & Africa Consumer Healthcare Drug Market Size by Type (2027-2032) & (US$ Million) Table 152. South America, Middle East & Africa Consumer Healthcare Drug Market Size by Application (2021-2026) & (US$ Million) Table 153. South America, Middle East & Africa Consumer Healthcare Drug Market Size by Application (2027-2032) & (US$ Million) Table 154. South America, Middle East & Africa Consumer Healthcare Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. South America, Middle East & Africa Consumer Healthcare Drug Market Size by Country (2021-2026) Table 156. South America, Middle East & Africa Consumer Healthcare Drug Market Size by Country (2027-2032) Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Consumer Healthcare Drug Product Image Figure 2. Global Consumer Healthcare Drug Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Consumer Healthcare Drug Market Share by Type: 2025 VS 2032 Figure 4. Patch Image Figure 5. Oral Liquid Image Figure 6. Solid Preparations Image Figure 7. Other Image Figure 8. Global Consumer Healthcare Drug Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Consumer Healthcare Drug Market Share by Application: 2025 VS 2032 Figure 10. Hospital Image Figure 11. Retail Pharmacy Image Figure 12. Other Image Figure 13. Global Consumer Healthcare Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Consumer Healthcare Drug Market Size (2021-2032) & (US$ Million) Figure 15. Global Consumer Healthcare Drug Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Consumer Healthcare Drug Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Consumer Healthcare Drug Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Consumer Healthcare Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Consumer Healthcare Drug Revenue Market Share by Type (2021-2032) Figure 22. Global Consumer Healthcare Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Consumer Healthcare Drug Revenue Market Share by Application (2021-2032) Figure 24. North America Consumer Healthcare Drug Market Size (2021-2032) & (US$ Million) Figure 25. North America Consumer Healthcare Drug Market Share by Type (2021-2032) Figure 26. North America Consumer Healthcare Drug Market Share by Application (2021-2032) Figure 27. North America Consumer Healthcare Drug Market Share by Country (2021-2032) Figure 28. United States Consumer Healthcare Drug Market Size (2021-2032) & (US$ Million) Figure 29. Canada Consumer Healthcare Drug Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Consumer Healthcare Drug Market Size (2021-2032) & (US$ Million) Figure 31. Europe Consumer Healthcare Drug Market Size (2021-2032) & (US$ Million) Figure 32. Europe Consumer Healthcare Drug Market Share by Type (2021-2032) Figure 33. Europe Consumer Healthcare Drug Market Share by Application (2021-2032) Figure 34. Europe Consumer Healthcare Drug Market Share by Country (2021-2032) Figure 35. Germany Consumer Healthcare Drug Market Size (2021-2032) & (US$ Million) Figure 36. France Consumer Healthcare Drug Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Consumer Healthcare Drug Market Size (2021-2032) & (US$ Million) Figure 38. Italy Consumer Healthcare Drug Market Size (2021-2032) & (US$ Million) Figure 39. Russia Consumer Healthcare Drug Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Consumer Healthcare Drug Market Size (2021-2032) & (US$ Million) Figure 41. China Consumer Healthcare Drug Market Size (2021-2032) & (US$ Million) Figure 42. China Consumer Healthcare Drug Market Share by Type (2021-2032) Figure 43. China Consumer Healthcare Drug Market Share by Application (2021-2032) Figure 44. Asia Consumer Healthcare Drug Market Size (2021-2032) & (US$ Million) Figure 45. Asia Consumer Healthcare Drug Market Share by Type (2021-2032) Figure 46. Asia Consumer Healthcare Drug Market Share by Application (2021-2032) Figure 47. Asia Consumer Healthcare Drug Market Share by Country (2021-2032) Figure 48. Japan Consumer Healthcare Drug Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Consumer Healthcare Drug Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Consumer Healthcare Drug Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Consumer Healthcare Drug Market Size (2021-2032) & (US$ Million) Figure 52. India Consumer Healthcare Drug Market Size (2021-2032) & (US$ Million) Figure 53. Australia Consumer Healthcare Drug Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Consumer Healthcare Drug Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Consumer Healthcare Drug Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Consumer Healthcare Drug Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Consumer Healthcare Drug Market Share by Country (2021-2032) Figure 58. Brazil Consumer Healthcare Drug Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Consumer Healthcare Drug Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Consumer Healthcare Drug Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Consumer Healthcare Drug Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Consumer Healthcare Drug Market Size (2021-2032) & (US$ Million) Figure 63. UAE Consumer Healthcare Drug Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Consumer Healthcare Drug Market Size (2021-2032) & (US$ Million) Figure 65. Chile Consumer Healthcare Drug Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Patch
  • Oral Liquid
  • Solid Preparations
  • Other
Applications
  • Hospital
  • Retail Pharmacy
  • Other
Companies covered
  • Takeda
  • Teva
  • Shanghai Pharmaceuticals
  • Sanofi
  • Johnson & Johnson
  • Merck & Co.
  • Pfizer
  • Hualan Bio
  • North China Pharmaceutical
  • Hengrui Medicine
  • GlaxoSmithKline
  • Bayer
  • AbbVie
  • Sinopharm Group
  • Livzon Group
  • Fosun Pharma
  • East China Medicine
  • CR Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Consumer Healthcare Drug Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Patch
  5. 1.2.3 Oral Liquid
  6. 1.2.4 Solid Preparations
  7. 1.2.5 Other
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Consumer Healthcare Drug Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Retail Pharmacy
  12. 1.3.4 Other
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Consumer Healthcare Drug Growth Trends by Region
  15. 1.5.1 Global Consumer Healthcare Drug Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Consumer Healthcare Drug Market Size by Region (2021-2026)
  17. 1.5.3 Consumer Healthcare Drug Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Consumer Healthcare Drug Market Dynamics
  1. 2.1 Consumer Healthcare Drug Industry Trends
  2. 2.2 Consumer Healthcare Drug Industry Drivers
  3. 2.3 Consumer Healthcare Drug Industry Opportunities and Challenges
  4. 2.4 Consumer Healthcare Drug Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Consumer Healthcare Drug Revenue by Company (2021-2026)
  2. 3.2 Global Consumer Healthcare Drug Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Consumer Healthcare Drug Key Company Head office and Area Served
  4. 3.4 Global Consumer Healthcare Drug Company, Product Type & Application
  5. 3.5 Global Consumer Healthcare Drug Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Consumer Healthcare Drug Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Consumer Healthcare Drug Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Consumer Healthcare Drug Tier 1, Tier 2, and Tier 3
4 Consumer Healthcare Drug Market by Type
  1. 4.1 Global Consumer Healthcare Drug Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Consumer Healthcare Drug Market Size by Type (2021-2032)
  3. 4.3 Global Consumer Healthcare Drug Market Size Share by Type (2021-2032)
5 Consumer Healthcare Drug Market by Application
  1. 5.1 Global Consumer Healthcare Drug Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Consumer Healthcare Drug Market Size by Application (2021-2032)
  3. 5.3 Global Consumer Healthcare Drug Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Takeda Consumer Healthcare Drug Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Teva
  8. 6.2.1 Teva Company Information
  9. 6.2.2 Teva Business Overview
  10. 6.2.3 Teva Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Teva Consumer Healthcare Drug Product Portfolio
  12. 6.2.5 Teva Recent Developments
  13. 6.3 Shanghai Pharmaceuticals
  14. 6.3.1 Shanghai Pharmaceuticals Company Information
  15. 6.3.2 Shanghai Pharmaceuticals Business Overview
  16. 6.3.3 Shanghai Pharmaceuticals Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Shanghai Pharmaceuticals Consumer Healthcare Drug Product Portfolio
  18. 6.3.5 Shanghai Pharmaceuticals Recent Developments
  19. 6.4 Sanofi
  20. 6.4.1 Sanofi Company Information
  21. 6.4.2 Sanofi Business Overview
  22. 6.4.3 Sanofi Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Sanofi Consumer Healthcare Drug Product Portfolio
  24. 6.4.5 Sanofi Recent Developments
  25. 6.5 Johnson & Johnson
  26. 6.5.1 Johnson & Johnson Company Information
  27. 6.5.2 Johnson & Johnson Business Overview
  28. 6.5.3 Johnson & Johnson Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Johnson & Johnson Consumer Healthcare Drug Product Portfolio
  30. 6.5.5 Johnson & Johnson Recent Developments
  31. 6.6 Merck & Co.
  32. 6.6.1 Merck & Co. Company Information
  33. 6.6.2 Merck & Co. Business Overview
  34. 6.6.3 Merck & Co. Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Merck & Co. Consumer Healthcare Drug Product Portfolio
  36. 6.6.5 Merck & Co. Recent Developments
  37. 6.7 Pfizer
  38. 6.7.1 Pfizer Company Information
  39. 6.7.2 Pfizer Business Overview
  40. 6.7.3 Pfizer Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Pfizer Consumer Healthcare Drug Product Portfolio
  42. 6.7.5 Pfizer Recent Developments
  43. 6.8 Hualan Bio
  44. 6.8.1 Hualan Bio Company Information
  45. 6.8.2 Hualan Bio Business Overview
  46. 6.8.3 Hualan Bio Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Hualan Bio Consumer Healthcare Drug Product Portfolio
  48. 6.8.5 Hualan Bio Recent Developments
  49. 6.9 North China Pharmaceutical
  50. 6.9.1 North China Pharmaceutical Company Information
  51. 6.9.2 North China Pharmaceutical Business Overview
  52. 6.9.3 North China Pharmaceutical Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 North China Pharmaceutical Consumer Healthcare Drug Product Portfolio
  54. 6.9.5 North China Pharmaceutical Recent Developments
  55. 6.10 Hengrui Medicine
  56. 6.10.1 Hengrui Medicine Company Information
  57. 6.10.2 Hengrui Medicine Business Overview
  58. 6.10.3 Hengrui Medicine Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Hengrui Medicine Consumer Healthcare Drug Product Portfolio
  60. 6.10.5 Hengrui Medicine Recent Developments
  61. 6.11 GlaxoSmithKline
  62. 6.11.1 GlaxoSmithKline Company Information
  63. 6.11.2 GlaxoSmithKline Business Overview
  64. 6.11.3 GlaxoSmithKline Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 GlaxoSmithKline Consumer Healthcare Drug Product Portfolio
  66. 6.11.5 GlaxoSmithKline Recent Developments
  67. 6.12 Bayer
  68. 6.12.1 Bayer Company Information
  69. 6.12.2 Bayer Business Overview
  70. 6.12.3 Bayer Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Bayer Consumer Healthcare Drug Product Portfolio
  72. 6.12.5 Bayer Recent Developments
  73. 6.13 AbbVie
  74. 6.13.1 AbbVie Company Information
  75. 6.13.2 AbbVie Business Overview
  76. 6.13.3 AbbVie Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 AbbVie Consumer Healthcare Drug Product Portfolio
  78. 6.13.5 AbbVie Recent Developments
  79. 6.14 Sinopharm Group
  80. 6.14.1 Sinopharm Group Company Information
  81. 6.14.2 Sinopharm Group Business Overview
  82. 6.14.3 Sinopharm Group Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Sinopharm Group Consumer Healthcare Drug Product Portfolio
  84. 6.14.5 Sinopharm Group Recent Developments
  85. 6.15 Livzon Group
  86. 6.15.1 Livzon Group Company Information
  87. 6.15.2 Livzon Group Business Overview
  88. 6.15.3 Livzon Group Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Livzon Group Consumer Healthcare Drug Product Portfolio
  90. 6.15.5 Livzon Group Recent Developments
  91. 6.16 Fosun Pharma
  92. 6.16.1 Fosun Pharma Company Information
  93. 6.16.2 Fosun Pharma Business Overview
  94. 6.16.3 Fosun Pharma Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Fosun Pharma Consumer Healthcare Drug Product Portfolio
  96. 6.16.5 Fosun Pharma Recent Developments
  97. 6.17 East China Medicine
  98. 6.17.1 East China Medicine Company Information
  99. 6.17.2 East China Medicine Business Overview
  100. 6.17.3 East China Medicine Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 East China Medicine Consumer Healthcare Drug Product Portfolio
  102. 6.17.5 East China Medicine Recent Developments
  103. 6.18 CR Pharmaceutical
  104. 6.18.1 CR Pharmaceutical Company Information
  105. 6.18.2 CR Pharmaceutical Business Overview
  106. 6.18.3 CR Pharmaceutical Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 CR Pharmaceutical Consumer Healthcare Drug Product Portfolio
  108. 6.18.5 CR Pharmaceutical Recent Developments
7 North America
  1. 7.1 North America Consumer Healthcare Drug Market Size (2021-2032)
  2. 7.2 North America Consumer Healthcare Drug Market Size by Type
  3. 7.2.1 North America Consumer Healthcare Drug Market Size by Type (2021-2026)
  4. 7.2.2 North America Consumer Healthcare Drug Market Size by Type (2027-2032)
  5. 7.2.3 North America Consumer Healthcare Drug Market Share by Type (2021-2032)
  6. 7.3 North America Consumer Healthcare Drug Market Size by Application
  7. 7.3.1 North America Consumer Healthcare Drug Market Size by Application (2021-2026)
  8. 7.3.2 North America Consumer Healthcare Drug Market Size by Application (2027-2032)
  9. 7.3.3 North America Consumer Healthcare Drug Market Share by Application (2021-2032)
  10. 7.4 North America Consumer Healthcare Drug Market Size by Country
  11. 7.4.1 North America Consumer Healthcare Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Consumer Healthcare Drug Market Size by Country (2021-2026)
  13. 7.4.3 North America Consumer Healthcare Drug Market Size by Country (2027-2032)
  14. 7.4.4 North America Consumer Healthcare Drug Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Consumer Healthcare Drug Market Size (2021-2032)
  2. 8.2 Europe Consumer Healthcare Drug Market Size by Type
  3. 8.2.1 Europe Consumer Healthcare Drug Market Size by Type (2021-2026)
  4. 8.2.2 Europe Consumer Healthcare Drug Market Size by Type (2027-2032)
  5. 8.2.3 Europe Consumer Healthcare Drug Market Share by Type (2021-2032)
  6. 8.3 Europe Consumer Healthcare Drug Market Size by Application
  7. 8.3.1 Europe Consumer Healthcare Drug Market Size by Application (2021-2026)
  8. 8.3.2 Europe Consumer Healthcare Drug Market Size by Application (2027-2032)
  9. 8.3.3 Europe Consumer Healthcare Drug Market Share by Application (2021-2032)
  10. 8.4 Europe Consumer Healthcare Drug Market Size by Country
  11. 8.4.1 Europe Consumer Healthcare Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Consumer Healthcare Drug Market Size by Country (2021-2026)
  13. 8.4.3 Europe Consumer Healthcare Drug Market Size by Country (2027-2032)
  14. 8.4.4 Europe Consumer Healthcare Drug Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Consumer Healthcare Drug Market Size (2021-2032)
  2. 9.2 China Consumer Healthcare Drug Market Size by Type
  3. 9.2.1 China Consumer Healthcare Drug Market Size by Type (2021-2026)
  4. 9.2.2 China Consumer Healthcare Drug Market Size by Type (2027-2032)
  5. 9.2.3 China Consumer Healthcare Drug Market Share by Type (2021-2032)
  6. 9.3 China Consumer Healthcare Drug Market Size by Application
  7. 9.3.1 China Consumer Healthcare Drug Market Size by Application (2021-2026)
  8. 9.3.2 China Consumer Healthcare Drug Market Size by Application (2027-2032)
  9. 9.3.3 China Consumer Healthcare Drug Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Consumer Healthcare Drug Market Size (2021-2032)
  2. 10.2 Asia Consumer Healthcare Drug Market Size by Type
  3. 10.2.1 Asia Consumer Healthcare Drug Market Size by Type (2021-2026)
  4. 10.2.2 Asia Consumer Healthcare Drug Market Size by Type (2027-2032)
  5. 10.2.3 Asia Consumer Healthcare Drug Market Share by Type (2021-2032)
  6. 10.3 Asia Consumer Healthcare Drug Market Size by Application
  7. 10.3.1 Asia Consumer Healthcare Drug Market Size by Application (2021-2026)
  8. 10.3.2 Asia Consumer Healthcare Drug Market Size by Application (2027-2032)
  9. 10.3.3 Asia Consumer Healthcare Drug Market Share by Application (2021-2032)
  10. 10.4 Asia Consumer Healthcare Drug Market Size by Country
  11. 10.4.1 Asia Consumer Healthcare Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Consumer Healthcare Drug Market Size by Country (2021-2026)
  13. 10.4.3 Asia Consumer Healthcare Drug Market Size by Country (2027-2032)
  14. 10.4.4 Asia Consumer Healthcare Drug Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Consumer Healthcare Drug Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Consumer Healthcare Drug Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Consumer Healthcare Drug Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Consumer Healthcare Drug Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Consumer Healthcare Drug Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Consumer Healthcare Drug Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Consumer Healthcare Drug Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Consumer Healthcare Drug Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Consumer Healthcare Drug Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Consumer Healthcare Drug Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Consumer Healthcare Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Consumer Healthcare Drug Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Consumer Healthcare Drug Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Consumer Healthcare Drug Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst